BNB PLUS CORP.
Business
BNB Plus Corp. operates a digital asset treasury accumulating and staking BNB cryptocurrency through Binance ecosystem protocols and DeFi opportunities. The company also develops proprietary nucleic acid production platforms through its LineaRx subsidiary, offering cell-free DNA and RNA manufacturing solutions for gene therapies, mRNA therapeutics, vaccines, and diagnostics. It distributes nucleic acid solutions directly to customers and through licensing arrangements.
Summary from 10-K filed 2025-12-22
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Total revenues | 2 | 2 | 13 | 18 | 9 | |
| Cost of product revenues | 1 | 1 | 8 | 13 | 5 | |
| Gross profit | 838,907 | 974,840 | 6 | 5 | 4 | |
| Selling, general and administrative | 11 | 11 | 13 | 15 | 13 | |
| Research and development | 6 | 4 | 4 | 4 | 4 | |
| Total operating expenses | 17 | 15 | 16 | 19 | 18 | |
| LOSS FROM OPERATIONS | −16 | −14 | −11 | −14 | −13 | |
| Interest income | 192,915 | 120,482 | 75,332 | — | — | |
| Transaction costs allocated to warrant liabilities | — | −633,198 | — | −2 | — | |
| Unrealized gain on change in fair value of warrants classified as a liability | 319,630 | 9 | 854,400 | 18 | 0 | |
| Unrealized loss on change in fair value of warrants classified as a liability-warrant modification | — | −394,000 | — | — | — | |
| Loss on issuance of warrants | — | −2 | — | −11 | 0 | |
| Other expense, net | −106,580 | −8,877 | 642 | −47,305 | −8,756 | |
| Loss before provision for income taxes | −16 | −7 | −10 | −8 | −14 | |
| Income tax provision benefit | 684,115 | 0 | 0 | 0 | 0 | |
| Net loss from continuing operations | −15 | −7 | — | — | — | |
| Net loss from discontinued operations, net of tax | −392,731 | −300,499 | — | — | — | |
| NET LOSS | −15 | −7 | −10 | −8 | −14 | |
| Less: Net loss attributable to noncontrolling interest | 188,522 | 95,785 | 75,857 | 2,168 | −8,003 | |
| NET LOSS attributable to BNB Plus Corp. | −15 | −7 | −10 | −8 | −14 | |
| Deemed dividend related to warrant modifications | −54 | −233,087 | — | 110,105 | — | |
| NET LOSS attributable to common stockholders | −69 | −7 | −10 | −8 | −14 | |
| Net loss per share attributable to common stockholders-continuing operations - basic (in dollars per share) | −133.47 | −1,310 | — | — | — | |
| Net loss per share attributable to common stockholders-continuing operations - diluted (in dollars per share) | −133.47 | −1,310 | — | — | — | |
| Net loss per share attributable to common stockholders-discontinued operations - basic (in dollars per share) | −0.76 | −56.83 | — | — | — | |
| Net loss per share attributable to common stockholders-discontinued operations - diluted (in dollars per share) | −0.76 | −56.83 | — | — | — | |
| Net loss income per share attributable to common stockholders - basic (in dollars per share) | −134.23 | −1,366 | −15.21 | −0.93 | −2.07 | |
| Net loss income per share attributable to common stockholders - diluted (in dollars per share) | −134.23 | −1,366 | −15.21 | −0.93 | −2.07 | |
| Weighted average shares outstanding- basic (in shares) | 517,671 | 5,288 | 653,771 | 9 | 7 | |
| Weighted average shares outstanding- diluted (in shares) | 517,671 | 5,288 | 653,771 | 9 | 7 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-11-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | 10 | 6 | 7 | 15 | |
| Accounts receivable, net of allowance for credit losses of $0 and $75,000 at September 30, 2025 and 2024, respectively | 237,400 | — | 328,252 | 255,502 | 3 | |
| Inventories | 84,102 | — | 432,725 | 330,027 | 602,244 | |
| Prepaid expenses and other current assets | 242,153 | — | 756,185 | 389,241 | 1 | |
| Current assets of discontinued operations | 6,971 | — | 678,146 | — | — | |
| Total current assets | 2 | — | 8 | 8 | 20 | |
| Property and equipment, net | 242,720 | — | 458,895 | 838,270 | 2 | |
| Noncurrent assets of discontinued operations | — | — | 94,337 | — | — | |
| Restricted cash | 750,000 | — | 750,000 | 750,000 | — | |
| Security deposit | 2,977 | — | — | — | — | |
| Intangible assets | — | — | 3 | 3 | — | |
| Operating right of use asset | 193,249 | — | 739,162 | 1 | — | |
| Deferred offering costs | 1 | — | — | — | — | |
| Total assets | 4 | — | 13 | 14 | 22 | |
| Accounts payable and accrued liabilities | 2 | — | 2 | 2 | 4 | |
| Operating lease liability, current | 193,250 | — | 545,912 | 498,598 | — | |
| Deferred revenue | 12,285 | — | 58,785 | 76,435 | 563,557 | |
| Current liabilities of discontinued operations | — | — | 56,061 | — | — | |
| Total current liabilities | 2 | — | 2 | 3 | 4 | |
| Long term accrued liabilities | 31,467 | — | 31,467 | 31,467 | 31,467 | |
| Deferred revenue, long term | — | — | 194,000 | 194,000 | — | |
| Operating lease liability, long term | — | — | 193,249 | 739,162 | — | |
| Deferred tax liability, net | — | — | 684,115 | 684,115 | — | |
| Warrants classified as a liability | 370 | — | 320,000 | 4 | 5 | |
| Total liabilities | 2 | — | 4 | 9 | 9 | |
| Commitments and contingencies (Note G) | — | — | — | — | — | |
| Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2025 and 2024 | — | — | — | — | 0 | |
| Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2025 and 2024; 1,662,601 and 13,755 shares issued and outstanding as of September 30, 2025 and 2024, respectively | 1,663 | — | 14 | 683 | 12,909 | |
| Additional paid in capital | 381 | — | 319 | 307 | 305 | |
| Accumulated deficit | −379 | — | −310 | −302 | −293 | |
| BNB Plus Corp., Inc. stockholders' equity | 2 | — | 9 | 5 | 13 | |
| Noncontrolling interest | −363,054 | — | −174,532 | −78,747 | −2,890 | |
| Total equity | 2 | — | 9 | 5 | 13 | |
| Total liabilities and equity | 4 | — | 13 | 14 | 22 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 384,165 | 432,595 | 1 | 1 | 844,438 | |
| Deferred income tax benefit | −684,115 | — | — | — | — | |
| Impairment of intangible asset | 3 | — | — | — | — | |
| Loss on write-off of property and equipment | 145,131 | — | 62,000 | — | — | |
| Unrealized gain on change in fair value of warrants classified as a liability | −319,630 | −9 | −854,400 | — | — | |
| Transaction costs allocated to warrant liabilities | — | 633,198 | — | — | — | |
| Shares issued Spindle earnout | — | 17,112 | — | — | — | |
| Stock-based compensation | 102,021 | 572,293 | 1 | 3 | 2 | |
| Bad debt expense | 6,465 | — | −239,043 | 269,451 | 28,629 | |
| Accounts receivable | −5,613 | −115,286 | 3 | −532,957 | −3 | |
| Inventories | 348,623 | −118,591 | 272,217 | 767,689 | −872,566 | |
| Prepaid expenses, other current assets and deposits | 511,055 | −391,687 | 767,812 | −493,220 | 30,415 | |
| Accounts payable and accrued liabilities | −516,716 | −412,172 | −1 | 930,497 | 94,711 | |
| Deferred revenue | 43,500 | −17,650 | −293,122 | 282,557 | −230,036 | |
| Net cash used in operating activities from continuing operations | −12 | −14 | — | — | — | |
| Purchase of property and equipment | −313,121 | −407,904 | −78,448 | −489,553 | −3 | |
| Net cash used in investing activities from continuing operations | −313,121 | −407,904 | — | — | — | |
| Net proceeds from exercise of warrants | 3 | 394 | — | 4 | 3 | |
| Capitalized offering costs | −166,341 | — | — | — | — | |
| Net proceeds from issuance of common stock and pre-funded warrants | 6 | 13 | — | — | — | |
| Net cash provided by financing activities from continuing operations | 8 | 13 | — | 18 | 15 | |
| Cash used in operating activities | −276,041 | −121,182 | — | — | — | |
| Cash provided by investing activities | 21,000 | 0 | — | — | — | |
| Net cash used in discontinued operations | −255,041 | −121,182 | — | — | — | |
| Net decrease in cash, cash equivalents and restricted cash | −5 | −720,705 | −7 | 9 | −1 | |
| Cash paid during period for income taxes | 2 | 7 | — | 0 | 0 | |
| Transaction costs included in accounts payable | 843,728 | — | — | — | — | |
| Deemed dividend warrant modifications | 54 | 233,087 | — | 110,105 | 0 | |
| Warrants issued, cashlessly | 1,314 | — | — | 26 | 0 | |
| Property and equipment acquired and included in accounts payable | — | 3,484 | — | 0 | 181,807 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is BNB PLUS CORP.'s CIK number?
BNB PLUS CORP.'s SEC CIK number is 0000744452 (744452). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find BNB PLUS CORP.'s SEC filings?
All of BNB PLUS CORP.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did BNB PLUS CORP. last report earnings?
BNB PLUS CORP. (BNBX) most recently filed an earnings 8-K with the SEC on Aug 14, 2025, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-25-078611). This is BNB PLUS CORP.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is BNB PLUS CORP.'s most recent earnings 8-K?
BNB PLUS CORP.'s latest earnings 8-K (Item 2.02) was filed Aug 14, 2025 under accession 0001104659-25-078611. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View BNB PLUS CORP.'s latest earnings 8-K →
Look up any company's CIK number →